Skip to main content

Horizons Marijuana Life Sciences ETF(HMMJ-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Horizons Marijuana Life Sciences ETF up on Monday (HMMJ)

Automated Summaries - The Globe and Mail - Mon Apr 8, 4:02PM CDT

Today in trading, Horizons Marijuana Life Sciences ETF shares closed at $11.29 after opening the day at $11.22. It traded at a low of $11.22 to a high of $11.56.

Shares advanced 0.36% from the previous day's close of $11.25.

During the day across North America, the TSX Composite closed 0.96% at 22264.38, the S&P 500 closed 1.11% at 5204.34, the Dow Jones Industrial Average closed 0.80% at 38904.04 and the Nasdaq Composite closed 1.24% at 16248.52.

Horizons Marijuana Life Sciences ETF traded under HMMJ on the Toronto Stock Exchange (TSX).

A total of 8,572 shares was traded during the session, with total trades of 55, with an average volume of 16,966 over the last 5 days.

Trading across the entire TSX saw 3,142 price advancers against 2,094 declines and 118 unchanged.

During the prior 52 weeks, HMMJ.TO has traded as high as $11.91 (April 04,2024) and low as $8.07 (October 27,2023). Moreover, the shares have boosted 10.04% in the last 12 months, while in 2024, they have boosted 21.53%.

Following today's trading, Horizons Marijuana Life Sciences ETF has a market capitalization of $92.71 million on a float of 8,241 shares outstanding. Its annual EPS is $None.

Horizons Marijuana Life Sciences ETF is a None company headquartered in, None.

The Horizons Marijuana Life Sciences Index ETF seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. The Index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry..

Horizons Marijuana Life Sciences ETF's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe